{"Content: ":"West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention, West China Hospital and Sichuan University. In August 2020, WestVac Biopharma started phase I clinical trials with 168 participants in China.[1] In November, WestVac Biopharma started phase II clinical trials with 960 participants in China[2] In February 2021, WestVac Biopharma started phase IIb clinical trials with 4,000 participants in China. Later, WestVac Biopharma is no longer on phase IIb clinical trial.[3] In June 2021, WestVac Biopharma started phase III trials with 40,000 participants including Indonesia, Kenya, and the Philippines.[4] In August 2021 WestVac Biopharma started phase I/II trials with 600 participants for children and adolescents aged 6-17.[5]  This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.","Title":"West China Hospital COVID-19 vaccine - Wikipedia","KeyID":"11181","URL":"https://en.wikipedia.org/wiki/West_China_Hospital_COVID-19_vaccine"}